Adverse effect of hemostatic drug, initial encounter

This code signifies an undesirable or harmful reaction experienced by a patient due to the therapeutic use of a hemostatic drug. These drugs are administered to promote blood clotting and stop bleeding, and an adverse effect indicates an unintended consequence of their intended action.

Apply this code when a patient presents with symptoms or complications directly attributable to a hemostatic drug, such as excessive clotting, thrombosis, or allergic reactions, during the initial phase of treatment. This includes situations where the adverse effect is being evaluated, diagnosed, or treated for the first time.

• Always sequence the adverse effect code first, followed by codes for the specific manifestation(s) of the adverse effect.
• Ensure documentation clearly links the adverse event to the hemostatic drug and specifies it as an adverse effect, not poisoning or underdosing.
• The "A" seventh character indicates an initial encounter for the adverse effect, meaning the patient is receiving active treatment for the condition.